Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

REGISTRO DE MANEJO DEL RITMO CIENTÍFICO DE BOSTON (SOCRATES) (SOCRATES)

30 de octubre de 2026 actualizado por: Boston Scientific Corporation

REGISTRO DE MANEJO DEL RITMO CIENTÍFICO DE BOSTON

SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Descripción detallada

SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.

SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.

SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.

The expected duration of SOCRATES participation for a subject is dependent on

  • the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or
  • the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.

For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.

Tipo de estudio

De observación

Inscripción (Estimado)

12500

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

  • Nombre: Jens B Goetzke, Dipl.Ing.
  • Número de teléfono: 1-800-227-3422
  • Correo electrónico: Jens.Goetzke@bsci.com

Ubicaciones de estudio

      • Berlin, Alemania, 12687
        • Reclutamiento
        • Unfallkrankenhaus Berlin Marzahn
        • Contacto:
          • Corinna Lenz, MD
      • Bochum, Alemania, 44791
        • Terminado
        • Augusta Kranken Anstalt GmbH
      • Jette, Bélgica, 1090
        • Reclutamiento
        • Universitair Ziekenhuis Brussel
        • Contacto:
          • Carlo de Asmundis, Prof.
      • Yvoir, Bélgica, 5530
        • Reclutamiento
        • CHU UCL Namur - Site Godinne
        • Contacto:
          • Dominique Blommaert, Prof.
    • Quebec
      • Québec, Quebec, Canadá, G1V 4G5
        • Reclutamiento
        • Institut Universitaire de Cardiologie et de Pneumologie de Quebec
        • Contacto:
          • Jean-Francois Sarrazin, MD
      • Madrid, España, 28040
        • Reclutamiento
        • Hospital Clinico San Carlos
        • Contacto:
          • Nicasio Pérez Castellano, MD
      • San Cristóbal de La Laguna, España, 38320
        • Reclutamiento
        • Hospital Universitario de Canarias
        • Contacto:
          • Francisco Bosa Ojeda, MD
      • Santa Cruz de Tenerife, España, 38010
        • Reclutamiento
        • Hospital Nuestra Señora de La Candelaria
        • Contacto:
          • Luis A. Acosta, MD
      • Zaragoza, España, 50009
        • Reclutamiento
        • Hospital Universitario Miguel Servet
        • Contacto:
          • Antonio Asso Abadía, MD
      • Brest, Francia, 29200
        • Reclutamiento
        • CHRU de Brest, Hôpital de la Cavale Blanche
        • Contacto:
          • Jacques Mansourati, Prof.
      • Clermont-Ferrand, Francia, 63000
        • Reclutamiento
        • CHRU de Clermont-Ferrand
        • Contacto:
          • Romain Eschalier, MD
      • Lomme, Francia, 59462
        • Reclutamiento
        • Hopital Saint Philibert
        • Contacto:
          • Aymeric Menet, MD
      • Pau, Francia
        • Reclutamiento
        • CHG de Pau
        • Contacto:
          • Hugues Bader, MD
      • Saint-Etienne, Francia, 42055
        • Reclutamiento
        • CHU de Saint-Etienne
        • Contacto:
          • Antoine Da Costa, Prof.
      • Athens, Grecia, 17674
        • Reclutamiento
        • Onassis Cardiac Surgery Center
        • Contacto:
          • Michael Ephremidis, MD
      • Athens, Grecia, 11527
        • Terminado
        • General Hospital of Athens "G. Gennimatas"
      • Dublin, Irlanda, D07 WKW8
        • Reclutamiento
        • Mater Private Hospital
        • Contacto:
          • Gabor Szeplaki, Prof.
      • Ramat Gan, Israel, 52621
        • Reclutamiento
        • Sheba Medical Center
        • Contacto:
          • Roy Beinart, MD
      • Tel Aviv, Israel, 6423906
        • Reclutamiento
        • Tel Aviv Sourasky Medical Center
        • Contacto:
          • Raphael Rosso, Professor
      • Tel Aviv, Israel, 62431
        • Reclutamiento
        • Tel Aviv Sourask Medical Center
        • Contacto:
          • Raphael Rosso, Professor
      • Modena, Italia, 41124
        • Reclutamiento
        • Policlinico di Modena
        • Contacto:
          • Giuseppe Boriani, Prof.
      • Roma, Italia, 00168
        • Reclutamiento
        • Policlinico Universitario Agostino Gemelli
        • Contacto:
          • Gemma Pelargonio, MD
      • Roma, Italia, 00169
        • Reclutamiento
        • Policlinico Casilino
        • Contacto:
          • Leonardo Calò, MD
      • Roma, Italia, 00186
        • Reclutamiento
        • Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina
        • Contacto:
          • Stefano Bianchi, MD
      • London, Reino Unido, EC1A 7BE
        • Reclutamiento
        • St. Bartholomew's Hospital
        • Contacto:
          • Ross Hunter, Prof.
      • Manchester, Reino Unido, M13 9WL
        • Reclutamiento
        • Manchester Heart Center
        • Contacto:
          • Charles Pearman, MD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

The subjects will be recruited from the general patient population of the participating centers who are

  • receiving diagnosis or treatment using a BSC product in scope of SOCRATES and
  • fulfilling all inclusion criteria and none of the exclusion criteria.

Descripción

Inclusion Criteria:

  1. Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
  2. Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.

Exclusion Criteria:

  1. Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
  2. Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: OTHER

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
BSC Product Use

Subject fulfilling one of the following conditions:

a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii.the BSC CRM product implant.

In the scope of the CRM procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific CRM products/components and combination of those products/components with competitor product(s) per hospital's standard of care.

In the scope of the EP procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific Electrophysiology products/components and capital equipment products and combination of those products/components with competitor product(s) per hospital's standard of care.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
System-related complication free rate
Periodo de tiempo: From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year

Freedom from complications related to system

From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
Rate of product related performance deficiencies per product or product group
Periodo de tiempo: CRM implant on day 0; EP procedure on day 0

Performance of product/product group at implant/procedure

CRM implant on day 0; EP procedure on day 0
Rate of product related performance deficiencies per product or product group
Periodo de tiempo: CRM implant on day 0 through the implanted duration up to 10 years

Performance of product/product group through the implanted duration

CRM implant on day 0 through the implanted duration up to 10 years

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Director de estudio: Eszter Pais, MD, Boston Scientific Corporation

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

31 de marzo de 2021

Finalización primaria (Estimado)

31 de diciembre de 2030

Finalización del estudio (Estimado)

31 de diciembre de 2030

Fechas de registro del estudio

Enviado por primera vez

18 de marzo de 2021

Primero enviado que cumplió con los criterios de control de calidad

26 de marzo de 2021

Publicado por primera vez (Actual)

1 de abril de 2021

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de octubre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir